Bioactive compounds from mangosteen (Garcinia mangostana L.) as an antiviral agent via dual inhibitor mechanism against SARSCoV-2: an in silico approach

ANM Ansori, VD Kharisma, AA Parikesit… - Pharmacognosy …, 2022 - phcogj.com
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is the virus that causes
COVID-19 which is responsible for respiratory illness infection in humans. The virus was first …

[HTML][HTML] In silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID …

T Ongtanasup, S Wanmasae, S Srisang… - Saudi journal of …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
coronavirus disease 2019 (COVID-19), is a new coronavirus strain that was first reported in …

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)

VA Falade, TI Adelusi, IO Adedotun… - In Silico …, 2021 - Springer
It is no longer news that a novel strain of coronavirus named SARS-CoV-2 is ravaging the
health sector worldwide, several attempts have been made to curtail this pandemic via …

[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …

Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences

RR Narkhede, AV Pise, RS Cheke… - Natural products and …, 2020 - Springer
Abstract SARS-CoV-2 (2019-nCoV) emerged in 2019 and proliferated rapidly across the
globe. Scientists are attempting to investigate antivirals specific to COVID-19 treatment. The …

In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2

SS Mousavi, A Karami, TM Haghighi, SG Tumilaar… - Molecules, 2021 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which initially appeared in Wuhan, China, in …

Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins

S Gupta, V Singh, PK Varadwaj… - Journal of …, 2022 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for
the current global pandemic that has caused a death toll of> 1.12 million worldwide and …

Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target

Umesh, D Kundu, C Selvaraj, SK Singh… - Journal of …, 2021 - Taylor & Francis
Abstract The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing
coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability …

Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual …

FM Abd El-Mordy, MM El-Hamouly, MT Ibrahim… - RSC …, 2020 - pubs.rsc.org
SARS-CoV-2 is a novel coronavirus that was first identified during the outbreak in Wuhan,
China in 2019. It is an acute respiratory illness that can transfer among human beings …

Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia …

P Shree, P Mishra, C Selvaraj, SK Singh… - Journal of …, 2022 - Taylor & Francis
Abstract COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and
propagated through a new virus strain SARS-CoV-2 (Severe Acute Respiratory Syndrome …